Economic impact of Alzheimer's disease in the United Kingdom : Cost of care and disease severity for non-institutionalised patients with Alzheimer's disease.
Background While the costs associated with Alzheimer's disease have been shown to be significant, there are few data relating cost ofcare to severity of the disease.
Aims We aimed to compare the costs associated with different severities of Alzheimer's disease with those incurred by control subjects over a three-month period.
Method In this cross-sectional, multicentre, naturalistic analysis, non-institutionalised patients with Alzheimer's disease (128), their care-givers (128), and 56 matched controls were interviewed once to establish resource use over the previous three months.
Patients were stratified into three severity groups according to their Mini Mental State Examination score.
Costs were calculated from the perspective of society as a whole.
Results Over the three-month period, total mean cost per control subject (£387) was minor compared with mean cost incurred by patients with mild (£6616). moderate (£10 250) and severe (£13 593) Alzheimer's disease.
Indirect cost, mainly time spent by care-givers, was the main cost component in all groups (68.6%). followed by direct medical costs (24.7%). Conclusions The cost of care for an Alzheimer's disease patient is directly related to the severity ofthe patient's illness.
Mots-clés Pascal : Démence Alzheimer, Soin, Analyse coût, Economie santé, Royaume Uni, Europe, Santé mentale, Personne âgée, Homme, Système nerveux pathologie, Système nerveux central pathologie, Encéphale pathologie, Maladie dégénérative
Mots-clés Pascal anglais : Alzheimer disease, Care, Cost analysis, Health economy, United Kingdom, Europe, Mental health, Elderly, Human, Nervous system diseases, Central nervous system disease, Cerebral disorder, Degenerative disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0123215
Code Inist : 002B17G. Création : 16/11/1999.